Balloon assisted chemoembolization (BACE) for hepatocellular carcinoma: evaluation of safety and efficary
Not Applicable
Recruiting
- Conditions
- hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000019172
- Lead Sponsor
- niversity of Tsukuba Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 52
Inclusion Criteria
Not provided
Exclusion Criteria
1)Rupture of hepatocellular carcinoma 2)History of surgical or endoscopic treatment of bile duct 3)Prominent arterioportal or arteriovenous shunts 4)Dissection or stenosis of 50% or more in the celiac trunk or hepatic artery 5)Hepatic coma or severe psychiatric disorder 6)Severe drug allergy including iodine contast allergy 7)Inadequate patients to undergo the procedure safely
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the safety of BACE, adverse events except for the side effects of chemoembolization are assessed according to SIR(Society of interventional radiology) standards of practice committee classification of complications by outcome.
- Secondary Outcome Measures
Name Time Method The efficacy of BACE is assessed on contrast enhanced CT or MRI after 3 month according to RECICL classification.